17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymphoma, or Sarcoma

ABSTRACT: Drugs used in chemotherapy work in different ways to stop cancer cells from dividing so they stop growing or die. This phase I trial is studying the side effects and best dose of 17-N-allylamino-17-demethoxygeldanamycin in treating patients with advanced epithelial cancer, malignant lymphoma, or sarcoma

DISEASE(S): Extranodal Marginal Zone B-cell Lymphoma Of Mucosa-associated Lymphoid Tissue,Lymphoma, Large B-cell, Diffuse,Sarcoma, Ewing,Ovarian Sarcoma,Chondrosarcoma,Stage Iv Adult T-cell Leukemia/lymphoma,Stage Iv Adult Diffuse Large Cell Lymphoma,Lymphoma, Large-cell, Immunoblastic,Neuroectodermal Tumors, Primitive,Recurrent Uterine Sarcoma,Small Intestine Lymphoma,Neuroectodermal Tumors,Stage Iv Adult Diffuse Mixed Cell Lymphoma,Recurrent Adult Soft Tissue Sarcoma,Stage Iv Adult Immunoblastic Large Cell Lymphoma,Recurrent Grade 1 Follicular Lymphoma,Sezary Syndrome,Splenic Marginal Zone Lymphoma,Mycosis Fungoides,Lymphoma, Mantle-cell,Stage Iv Adult Lymphoblastic Lymphoma,Aids-related Peripheral/systemic Lymphoma,Leukemia-lymphoma, Adult T-cell,Recurrent Adult Immunoblastic Large Cell Lymphoma,Recurrent Adult Burkitt Lymphoma,Stage Iv Grade 1 Follicular Lymphoma,Stage Iv Mantle Cell Lymphoma,Leukemia, T-cell,Primary Central Nervous System Non-hodgkin Lymphoma,Stage Iv Mycosis Fungoides/sezary Syndrome,Plasmablastic Lymphoma,Aids-related Primary Cns Lymphoma,Lymphoma, B-cell, Marginal Zone,Burkitt Lymphoma,Recurrent Adult Diffuse Small Cleaved Cell Lymphoma,Nodal Marginal Zone B-cell Lymphoma,Recurrent Small Lymphocytic Lymphoma,Lymphoma, T-cell, Cutaneous,Stage Iv Adult Burkitt Lymphoma,Recurrent Marginal Zone Lymphoma,Lymphoma, Follicular,Leukemia, Lymphocytic, Chronic, B-cell,Recurrent Ewing Sarcoma/peripheral Primitive Neuroectodermal Tumor,Intraocular Lymphoma,Recurrent Mantle Cell Lymphoma,Recurrent Grade 3 Follicular Lymphoma,Stage Iv Uterine Sarcoma,Leukemia,Hodgkin Disease,Recurrent Adult Hodgkin Lymphoma,Mycoses,Recurrent Adult Lymphoblastic Lymphoma,Angioimmunoblastic T-cell Lymphoma,Stage Iv Marginal Zone Lymphoma,Unspecified Adult Solid Tumor, Protocol Specific,Osteosarcoma,Lymphoma, Large-cell, Anaplastic,Stage Iv Adult Hodgkin Lymphoma,Metastatic Osteosarcoma,Lymphoma, T-cell,Neuroectodermal Tumors, Primitive, Peripheral,Stage Iv Grade 3 Follicular Lymphoma,Stage Iv Adult Diffuse Small Cleaved Cell Lymphoma,Sarcoma,Immunoblastic Lymphadenopathy,Precursor Cell Lymphoblastic Leukemia-lymphoma,Recurrent Cutaneous T-cell Non-hodgkin Lymphoma,Stage Iv Small Lymphocytic Lymphoma,Lymphoma,Recurrent Mycosis Fungoides/sezary Syndrome,Anaplastic Large Cell Lymphoma,Recurrent Adult Diffuse Mixed Cell Lymphoma,Recurrent Osteosarcoma,Recurrent Grade 2 Follicular Lymphoma,Stage Iv Cutaneous T-cell Non-hodgkin Lymphoma,Recurrent Adult T-cell Leukemia/lymphoma,Stage Iv Grade 2 Follicular Lymphoma,Lymphoma, Non-hodgkin,Recurrent Adult Diffuse Large Cell Lymphoma,Lymphoma, B-cell,Stage Iv Adult Soft Tissue Sarcoma,Metastatic Ewing Sarcoma/peripheral Primitive Neuroectodermal Tumor

PROVIDER: 2003652 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR